Page last updated: 2024-11-06

cephaloridine and Parkinson Disease

cephaloridine has been researched along with Parkinson Disease in 1 studies

Cephaloridine: A cephalosporin antibiotic.
cefaloridine : A cephalosporin compound having pyridinium-1-ylmethyl and 2-thienylacetamido side-groups. A first-generation semisynthetic derivative of cephalosporin C.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tomioka, H1
Kobayashi, Y1
Tamatani, S1
Morishita, T1
Hasegawa, Y1

Other Studies

1 other study available for cephaloridine and Parkinson Disease

ArticleYear
[Amikacin treatment of septicemia due to gentamicin-resistant gram-negative bacilli (author's transl)].
    The Japanese journal of antibiotics, 1975, Volume: 28, Issue:3

    Topics: Aged; Amikacin; Aorta, Thoracic; Aortic Aneurysm; Cephaloridine; Drug Resistance, Microbial; Gentami

1975